Julien Hogan Profile
Julien Hogan

@julien_hogan

Followers
309
Following
902
Media
33
Statuses
433

Joined February 2018
Don't wanna be here? Send us removal request.
@julien_hogan
Julien Hogan
7 months
4/ A huge thank you to our collaborators! @EmoryMedicine @childrensatl @APHP @univ_paris_cite @Inserm @parcc_inserm @OrganX_Official @AlexandreLoupy @MRabant @olivieraubert_ Rouba Garro Roshan George Carissa Hayes Véronique Baudouin Elodie Cheyssac Charlotte Duneton @KamelMargo
1
0
1
@julien_hogan
Julien Hogan
7 months
3/ We validated a prediction model combining standard of care and dd-cfDNA published last year in @NatureMedicine https://t.co/VGA52zJ0UN, demonstrating that adding dd-cfDNA to standard of care improves the prediction of rejection in children.
1
1
1
@julien_hogan
Julien Hogan
7 months
2/ dd-cfDNA was associated with acute rejection
1
1
1
@julien_hogan
Julien Hogan
7 months
In this large unselected pediatric cohort: 1/dd-cfDNA was strongly associated with the degree of tubulo-interstitial and microvascular inflammation
1
1
1
@Bacchetta_J
Justine Bacchetta Guidici
11 months
Pour commencer 2025 du bon pied, premier webinar SNP francophonie le 9 janvier: regards croisés autour de de la maladie rénale chronique pédiatrique. Diffusez à vos réseaux, nous vous attendons nombreux ! @SNephroPed @FiliereORKiD @EuRefNetwork @IPNA_PedNeph @CHUdeLyon
0
4
2
@julien_hogan
Julien Hogan
1 year
Another great collaborative work from our team just published in @NEJM analyzing over 16000 biopsies including over 2500 biopsies from 1000 pediatric recipients and providing insight into microvascular inflammation in kidney allograft. Check it out 👇 https://t.co/DZY8PLaK25
@NEJM
NEJM
1 year
Kidney-transplant microvascular inflammation has a varied clinical presentation. This study of more than 16,000 biopsy specimens supports the recognition of additional rejection phenotypes to standardize diagnostics. https://t.co/FzWH6RAY28 #KidneyWk
1
9
22
@univ_paris_cite
Université Paris Cité
1 year
La conférence internationale Banff 2024 s’est achevée vendredi 20 septembre, à l’@univ_paris_cite, après avoir réuni 350 spécialistes venus du monde entier. Accueillie à Paris par le @ParisTxGroup (PITOR) de l’université Paris Cité, leader européen en matière de transplantation
0
13
21
@PedNephParis_RD
PedNephParis_RD
1 year
🚀 On démarre cette rentrée 2024 avec une journée rencontre #maladiesrares à l'hôpital RDB : le Dr Claire Dossier présente les activités et missions du centre de référence des maladies rénales rares . 👉 https://t.co/1WbaMJGP6L #rein #néphrologie #transplantation #dialyse
0
1
1
@julien_hogan
Julien Hogan
1 year
So exciting to see our study on #kidney #transplant rejection prediction using #ddcfDNA published in @NatureMedicine ... for my #pediatric colleagues...it is also validated in #children! @olivieraubert_ @AlexandreLoupy @IPNA_PedNeph @ESPNSociety @SNephroPed @ASPNeph @IptaPedsTx
@NatureMedicine
Nature Medicine
1 year
Now at #ATC2024Philly : A prospective observational study including 2,882 kidney allograft recipients from 14 centers in Europe and the US shows that cell-free DNA can be used to detect kidney allograft rejection @AlexandreLoupy @olivieraubert
1
9
29
@julien_hogan
Julien Hogan
1 year
#nephrotic syndrome in #children is an autoimmune disease! Thank you so much @Tobias_B_Huber @hengel_f for leading this work and including #children and our #NEPHROVIR cohort. Major impact for management and treatment! @APHP @HopRobertDebre @SNephroPed @IPNA_PedNeph @ESPNSociety
@NEJM
NEJM
1 year
Original Article: Autoantibodies Targeting Nephrin in Podocytopathies https://t.co/kJLkUQJQH2 @ERAkidney | #Nephrology #ERA24
1
2
18
@ParisTxGroup
Paris Transplant Group
2 years
At #PTG #PITOR @parcc_inserm @univ_paris_cite our weekly meeting on Fridays to present results and bibliography.
@TheLancet
The Lancet
2 years
The use of artificial intelligence (AI) in health care has seen remarkable growth in the past 5 years. A new Review from @LancetDigitalH examines how AI could improve care management, clinical decision-making efficiency, and further research areas 👉 https://t.co/P3uIXMMsCx
1
6
11
@julien_hogan
Julien Hogan
2 years
Fière de mon équipe @PedNephParis_RD pour cette 1ère, merci à @HopRobertDebre pour le soutien et à nos patients pour leur confiance! L'#hemodialyse à la maison ca change la vie et c'est possible à tout age. @FranceRein @AirgFrance @Renalooo @SNephroPed @APHP
@APHP
Assistance Publique – Hôpitaux de Paris (AP-HP)
2 years
1er programme d'hémodialyse pédiatrique à domicile lancé en France à @HopRobertDebre 👉2h d’hémodialyse par jour chez soi (contre 3 séances de 4h hebdomadaires à l'hôpital) Une amélioration considérable de la qualité de vie des patients atteints d’#IRC 🔗 https://t.co/vQtnz3wGPi
2
5
29
@HopRobertDebre
Hôpital Robert-Debré AP-HP
2 years
#semainenationaledurein | 🚀Inauguration du programme d’hémodialyse pédiatrique à domicile porté par les équipes de néphrologie-hémodialyse de @HopRobertDebre @APHP 👏Bravo pour cette première en France, synonyme d’amélioration de la qualité de vie des patients !
0
2
14
@julien_hogan
Julien Hogan
2 years
Adjunction of #Daratumumab to B-cell depletion is effective in #FSGS #recurrence after #kidney #transplantation but the optimal treatment sequence remains to be defined! Read the interesting report from Angelleti et al. https://t.co/BjGFaFtHi8 and our response
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
Focal segmental glomerulosclerosis (FSGS) is one of the leading causes of kidney failure and it is characterized by a high rate of recurrence after kidney transplant. Moreover, FSGS recurrence is...
1
0
0
@julien_hogan
Julien Hogan
2 years
Congratulation @cohencamille1 !
0
0
1
@julien_hogan
Julien Hogan
2 years
Great work @DivardG and @DanielYoo1109!
@DivardG
Gillian Divard
2 years
🚀🚀Exciting News @DanielYoo1109 and I are delighted to share with you this new publication from @ParisTxGroup published in @NatureComms 🔗 https://t.co/shUpTPd63h thread⤵️
1
0
3